AbbVie announced a late-stage study found its hepatitis C treatment Viekira Pak was effective with our without compound ribavirin, according to a Reuters report.
Boston Scientific‘s short interest dropped 11.9 percent from May 15 to May 29, according to a report from The Legacy.
EndoGastric Solutions appointed three new members to its executive team. The new appointments include:
• Adrian Lobontiu, MD, FACS, as medical director
• Philip Macdonald as vice president of healthcare economics, policy and reimbursement
• Mike Zagger as vice president of sales and marketing
https://www.beckersasc.com/gastroenterology-and-endoscopy/endogastric-solutions-adds-3-new-executive-team-members.html
gMed held its annual group user conference, the gMed Summit, in Fort Lauderdale, Fla., on June 18 to June 20.
Valeant Pharmaceuticals and Progenics Pharmaceuticals submitted a new drug application to the FDA for RELISTOR, an oral treatment for opioid-induced constipation, according to a Nasdaq report.
If you have a question, issue or note to suggest on a GI/endoscopy company please contact Carrie Pallardy at cpallardy@beckershealthcare.com.
More articles on gastroenterology:
6 must-reads on colonoscopy
CCFA names new president, CEO: 5 things to know
AGA raises $10.5M for digestive disease, hepatology research
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
